REQUEST A DEMO
Total
USD $0.00
Search more companies

Abl Pharma Ecuador S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Residential Building Construction | Lessors of Real Estate | Marketing Research and Public Opinion Polling
Full name: Abl Pharma Ecuador S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Importación, exportación, comercialización, representación, distribución, promoción y producción en todas sus fases de todo tipo de productos farmacéuticos de consumo humano o productos veterinarios

Headquarters
Paraiso Km. 6 1/12, Grunenthal Bldg.
Quito; Pichincha;

Contact Details: Purchase the Abl Pharma Ecuador S.A. report to view the information.

Website: http://www.ablpharma.com

Basic Information
Total Employees:
Purchase the Abl Pharma Ecuador S.A. report to view the information.
Outstanding Shares:
Purchase the Abl Pharma Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Abl Pharma Ecuador S.A. report to view the information.
Incorporation Date:
January 02, 2002
Key Executives
Purchase this report to view the information.
Administrative Manager
Purchase this report to view the information.
Administrative Manager
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Abl Pharma Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-13.9%
Total equity
14.17%
Return on Equity (ROE)
N/A
Quick Ratio
0%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?